Results 11 to 20 of about 58,257 (152)

Formulation and evaluation of oxymetazoline hydrochloride nasal gels [PDF]

Journal of Drug Delivery and Therapeutics, 2018
The main intend of the implement sniff out formulate and evaluate oxymetazoline nasal gels. To achieve more persistent blood levels with decrease dosage of medicine by extended drug evidence and by passing hepatic initially cross metabolism and body including inferable disgrace.
K Sujatha, A.S.L.S.M. Sravya, SK Neha Sulthana, S Kaveri, Sri K Gnana, B Abhirami, Yerikala Ramesh   +6 more
openaire   +3 more sources

Effect of various chemical agents used in gingival retraction systems on smear layer: Scanning electron microscope study

Contemporary Clinical Dentistry, 2016
Background: Chemical agents used for gingival retraction affects the smear layer. Aim: To determine the effect of three different chemical agents used for gingival retraction systems on smear layer.
Krishna Shivraj Lahoti
doaj   +2 more sources

Evaluation of the dose-response relationship for intra-nasal oxymetazoline hydrochloride in normal adults

European Journal of Clinical Pharmacology, 1999
To evaluate the dose-response relationship of increasing doses of oxymetazoline compared with placebo in normal subjects, and to determine the sensitivities of rhinomanometry, acoustic rhinometry and symptoms in discriminating between differing doses of oxymetazoline in normal subjects.The study had a randomized, double-blind, placebo-controlled ...
Taverner, D., Bickford, L., Shakib, S., Tonkin, A.   +3 more
openaire   +4 more sources

A review of nonsurgical facial rejuvenation and the role of oxymetazoline hydrochloride ophthalmic solution, 0.1% in periorbital revitalization

Journal of Cosmetic Dermatology
AbstractBackgroundThe demand for nonsurgical facial rejuvenation options is growing, yet the periorbital region remains an area of relative unmet need. This review explores nonsurgical options for facial rejuvenation and the role of oxymetazoline hydrochloride ophthalmic solution, 0.1%, in treating age‐related blepharoptosis as part of periorbital ...
David J. Goldberg, Anneke Andriessen, Michael Gold, Margarita S. Lolis, Shari Marchbein, Mark S. Nestor, Adriana Ros   +6 more
openaire   +3 more sources

Indirect Spectrophotometric Determination of Oxymetazoline Hydrochloride in Pharmaceutical Formulation Using Fluorophotometric Method

Ibn Al-Haitham Journal for Pure and Applied Sciences, 2017
This research involves an indirect Fluorophotometric method for the determination of microgram amount of oxymetazoline hydrochloride in the concentration range 0.1-5.0 g/ml.
Mohammed S. Saleem, Ikram K. Othman
doaj   +1 more source

Oxymetazoline Hydrochloride Eye-Drops as Treatment for Myasthenia Gravis-Related Ptosis: A Description of Two Cases. [PDF]

Cureus, 2023
In this article, we described two patients with myasthenia gravis-related ptosis who experienced sustained improvement with the use of oxymetazoline hydrochloride ophthalmic solution 0.1%. Despite the commonly used treatments for ptosis in myasthenia gravis (MG), such as acetylcholinesterase inhibitors and corticosteroids, complete remission of ptosis ...
Taha M, Li Y, Morren J.
europepmc   +3 more sources

Tissue Biocompatibility and Antimicrobial Properties of Sympathomimetic Nasal Solutions for Potential Use in Dental Pulpal Management. [PDF]

Clin Exp Dent Res
ABSTRACT Objectives Sympathomimetic nasal solutions (SNS), containing oxymetazoline or phenylephrine, may be used directly onto dental pulp tissue and initiate hemostasis via activation of alpha‐receptors that innervate arteriole smooth muscles. The aim of this study was to assess these SNS's biocompatibility with human dental pulp stem cells (hDPSCs ...
Jones RS, Garcia R, Mutreja I, Kumar D.
europepmc   +2 more sources

Iatrogenic Blepharoptosis: Multimodal Management and Treatment Technique With Botulinum Toxin Type A. [PDF]

Dermatol Res Pract
Blepharoptosis as an Aesthetic Complication Eyelid ptosis, or blepharoptosis, following esthetic treatment of the upper third with botulinum toxin Type A (BoNT‐A) is a complication with a variable incidence depending on the injector’s experience. Among unexperienced injectors, it ranges from 2.5% to 5.4% and approximately 0.51% to 1% in experienced ...
Jaime Alberto RP, Paola Andrea MA, Maria Paulina UP, Luisa LB.   +3 more
europepmc   +2 more sources

Efficacy and Safety of Oxymetazoline 1% Cream for the Treatment of Mild to Moderate Facial Rosacea. [PDF]

J Cosmet Dermatol
ABSTRACT Introduction Rosacea is a common skin condition that affects the physical and mental health of the patient. The objective of this study was to evaluate the efficacy and safety of oxymetazoline 1% cream, a specific α1A‐adrenoceptor agonist, for the treatment of mild to moderate facial rosacea.
Sajdeh F, Samadi A, Naeimifar A, Yazdanparast T, Ahmadi M, Amiri F, Kassir M, Firooz A, Nasrollahi SA.   +8 more
europepmc   +2 more sources

Oxymetazoline hydrochloride combined with mometasone nasal spray for persistent nasal congestion (pilot study). [PDF]

World Allergy Organ J, 2011
Rael EL, Ramey J, Lockey RF.
europepmc   +3 more sources